 | Up a level |
Hao, Qiukui; Aertgeerts, Bert; Guyatt, Gordon; Bekkering, Geertruida E; Vandvik, Per Olav; Khan, Safi U; Rodondi, Nicolas; Jackson, Rod; Reny, Jean-Luc; Al Ansary, Lubna; Van Driel, Mieke; Assendelft, Willem J J; Agoritsas, Thomas; Spencer, Frederick; Siemieniuk, Reed A C; Lytvyn, Lyubov; Heen, Anja Fog; Zhao, Qian; Riaz, Irbaz Bin; Ramaekers, Dirk; ... (2022). PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ, 377, e069066. BMJ Publishing Group 10.1136/bmj-2021-069066
Cleynen, Isabelle; Jüni, Peter; Bekkering, Geertruida E; Nüesch, Eveline; Mendes, Camila T; Schmied, Stefanie; Wyder, Stefan; Kellen, Eliane; Villiger, Peter M; Rutgeerts, Paul; Vermeire, Séverine; Lottaz, Daniel (2011). Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS ONE, 6(9), e24106. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0024106
Bekkering, Geertruida E; Rutjes, Anne W S; Vlassov, Vasiliy V; Aebersold, Daniel M; von Bremen, Konrade; Jüni, Peter; Kleijnen, Jos (2009). The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review. Strahlentherapie und Onkologie, 185(4), pp. 211-21. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-009-1900-4
